Medicated Skin Care - Kenya

Date: June 22, 2010
Pages: 24
Price:
US$ 990.00
Publisher: Euromonitor International Ltd
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: MF2E152905EEN
Leaflet:

Download PDF Leaflet

In 2009, medicated skin care achieved retail value growth of 2% despite a decrease in demand during the first quarter of the year due to the political and economic unrest of 2008. This steady growth was due to increased abuse of products, particularly Betasone, as many consumers, particularly young consumers, misuse such products by purchasing them without a prescription, in order to obtain clear, smooth and pale skin.

Euromonitor International's Medicated Skin Care Products in Kenya report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.

Product coverage: Acne Treatments, Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Child-Specific Medicated Skin Care, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Consumer Health industry;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Executive Summary
A Shaky Start To 2009 Impacted Consumer Healthcare
Recovery Having Positive Impact on OTC
GlaxoSmithKline East Africa Ltd Continues To Lead in Consumer Healthcare
Chemists/pharmacies Remain the Leading Distribution Channel
Improvement on Its Way
Market Indicators
  Table 1 Consumer Expenditure on Health Goods and Medical Services 2004-2009
  Table 2 Life Expectancy at Birth 2004-2009
Market Data
  Table 3 Sales of Consumer Health by Sector: Value 2004-2009
  Table 4 Sales of Consumer Health by Sector: % Value Growth 2004-2009
  Table 5 Consumer Health Company Shares by Value 2005-2009
  Table 6 Consumer Health Brand Shares by Value 2006-2009
  Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009
  Table 8 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009
  Table 9 Forecast Sales of Consumer Health by Sector: Value 2009-2014
  Table 10 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014
Appendix
OTC Registration and Classification
Regulation
Delisting Or Dereimbursement
Advertising
Packaging
Labelling
Distribution
Vitamins and Dietary Supplements Registration and Classification
Generics
Switches
Definitions
Sector and Subsector Definitions
  Summary 1 Research Sources
Biodeal Laboratories Ltd
Strategic Direction
Key Facts
  Summary 2 Biodeal Laboratories Ltd: Key Facts
Company Background
Production
Competitive Positioning
  Summary 3 Biodeal Laboratories Ltd: Competitive Position 2009
Cosmos Ltd
Strategic Direction
Key Facts
  Summary 4 Cosmos Ltd: Key Facts
Company Background
Production
Competitive Positioning
  Summary 5 Cosmos Ltd: Competitive Position 2009
Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
  Table 11 Sales of Medicated Skin Care by Subsector: Value 2004-2009
  Table 12 Sales of Medicated Skin Care by Subsector: % Value Growth 2004-2009
  Table 13 Medicated Skin Care Company Shares by Value 2005-2009
  Table 14 Medicated Skin Care Brand Shares by Value 2006-2009
  Table 15 Hair Loss Treatments Brand Shares by Value 2006-2009
  Table 16 Forecast Sales of Medicated Skin Care by Subsector: Value 2009-2014
  Table 17 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2009-2014
Skip to top


Medicated Skin Care in Kenya US$ 990.00 Sep, 2012 · 24 pages
Medicated Skin Care in Lithuania US$ 990.00 Mar, 2012 · 27 pages
Medicated Skin Care in Macedonia US$ 990.00 May, 2012 · 23 pages

Ask Your Question

Medicated Skin Care - Kenya
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: